Work with thought leaders and academic experts from University of Warwick

My name is Ali Aslan Gümüsay. I work within the fields of **Organization Theory**, **Entrepreneurship**, **Business Ethics** and **Leadership**, am Head of the Innovation, Entrepreneurship & Society Research Group at the Humboldt Institute for Internet & Society and postdoctoral researcher at the University of Hamburg. Currently, I am a Visiting Research Fellow at Judge Business School, Visiting Associate at Hughes Hall, and Visiting Scholar at the Leverhulme Centre for the Future of Intelligence, University of Cambridge. Before, I was a DAAD PRIME Fellow, Lecturer at Magdalen College, and a DPhil Candidate at Saïd Business School, University of Oxford. At the heart of my research are concerns around **Organizing in & for Society**. It is guided by four questions: 1. How do values and meaning shape organizations and how are they managed? 2. How do new forms of organizing impact and deal with societal Grand Challenges? 3. How can engaged, passionate, humble, relevant, and meaningful scholarship as well as soci(et)al complexity and diversity be ingrained in academic practices? 4. How do socio-technological transformations such as AI shape the Future of Work? My work has been published in journals such as *Academy of Management Journal*, *Academy of Management Perspectives*, *Business & Society*, *Innovation: Organization & Management*, *Journal of Business Ethics*, *Journal of Management Studies* and *Research Policy*.

I am a machine learning expert with a focus on easy-to-deploy inference engines. With a background in building efficient intelligent systems in my doctoral research, I have created innovative solutions for a major US airline and a leading auto parts supplier. My professional journey encompasses academic pursuits, a role as an accelerometer-systems engineer in Silicon Valley, CTO of a brokerage firm, CEO of two startups, software process improvement, and industrial controls.

Dr. Jinyu Shan stands as a pivotal figure in molecular microbiology, seamlessly integrating an illustrious academic career with significant contributions to industry innovation. Fluent in English and Mandarin Chinese, and proficient in Cantonese, Dr. Shan leverages his linguistic capabilities to foster international collaborations and effectively communicate complex scientific concepts. Holding advanced degrees from renowned institutions like Shandong University, Nankai University, and the University of Warwick, Dr. Shan's extensive educational background lays the foundation for his groundbreaking work in both academia and biotechnology. His efforts are particularly notable in the fields of phage therapy and molecular diagnostics for bacterial infections such as Lyme and tick-borne diseases, where he combines research excellence with practical application and citizen sciences to address pressing public health needs. At the University of Leicester and Phelix Research & Development, Dr. Shan has led pioneering research in phage-based diagnostics and therapies and directed the development and commercialization (IP licencing) of innovative diagnostic kits, adhering to strict ISO standards. His leadership roles at Youseq Ltd, Marker Diagnostics Ltd and Rosalind Franklin Laboratory have further showcased his expertise in developing biomarkers and managing laboratory operations to meet ISO15189 standards. Dr. Shan's scholarly output includes influential publications on novel diagnostic methods and active engagement in public health through citizen science projects and popular science articles, establishing him as a leader in his field. He is a sought-after speaker at international microbiology and infectious disease conferences, reflecting his commitment to scientific education and mentoring. Dr. Shan is actively involved with professional societies and has served as a judge for the LymeX Diagnostics Prize Competition, highlighting his dedication to advancing Lyme disease diagnostics. His interdisciplinary approach exemplifies his commitment to improving public health through innovative biomedical research. Recently, Dr. Shan's work has gained additional acclaim as he joined the BBSRC ICURe Programme, aimed at commercializing his phage-based Lyme diagnostic technologies. This recognition underscores the impact and commercial potential of his research, bridging the gap between laboratory discoveries and clinical application, thus advancing patient care globally. This achievement marks a significant milestone in Dr. Shan's career, emphasizing his influence as a driving force in the evolution of infectious disease diagnostics.

With over six years of experience as an Assistant Professor at Harvard Business School, I am passionate about advancing the field of household financial decision making and improving the financial well-being of millions of people. My research leverages transactions level data to explore topics such as informal social insurance, housing affordability, and climate risk impacts on households. I strive to produce rigorous, relevant, and impactful research that can inform policy and practice, and to inspire and mentor the next generation of scholars and leaders in finance. <br> In my current role, I work on various projects that examine the financial behavior and choices of individuals and households in the United States. For example, one of my recent papers investigates how informal risk-sharing arrangements among friends and family affect consumption smoothing. Another paper studies how the rising cost of housing affects household saving, borrowing, and mobility. I also teach courses on core finance topics to MBA students, and supervise doctoral students and research assistants. I use my skills in data analysis, econometrics, and economics to conduct rigorous and innovative research, and to create engaging learning experiences for my students.

Experienced academic and consultant.